149 related articles for article (PubMed ID: 21206974)
1. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.
Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK
Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract][Full Text] [Related]
3. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: novel targets for gastric cancer.
Song Y; Tian Y; Zuo Y; Tu JC; Feng YF; Qu CJ
Mol Med Rep; 2013 Apr; 7(4):1159-68. PubMed ID: 23440386
[TBL] [Abstract][Full Text] [Related]
5. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.
Wolf I; Bose S; Desmond JC; Lin BT; Williamson EA; Karlan BY; Koeffler HP
Breast Cancer Res Treat; 2007 Oct; 105(2):139-55. PubMed ID: 17295047
[TBL] [Abstract][Full Text] [Related]
6. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
Bondurant AE; Huang Z; Whitaker RS; Simel LR; Berchuck A; Murphy SK
Gynecol Oncol; 2011 Dec; 123(3):581-7. PubMed ID: 21955482
[TBL] [Abstract][Full Text] [Related]
9. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
10. FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.
De La Chesnaye E; Méndez JP; López-Romero R; De Los Angeles Romero-Tlalolini M; Vergara MD; Salcedo M; Ojeda SR
Int J Clin Exp Pathol; 2015; 8(9):10192-203. PubMed ID: 26617728
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.
Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706
[TBL] [Abstract][Full Text] [Related]
14. High-throughput DNA hypermethylation profiling in different ovarian epithelial cancer subtypes using universal bead array.
Yoon MS; Suh DS; Choi KU; Sol MY; Shin DH; Park WY; Lee JH; Jeong SM; Kim WG; Shin NR
Oncol Rep; 2010 Oct; 24(4):917-25. PubMed ID: 20811671
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
[TBL] [Abstract][Full Text] [Related]
16. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
[TBL] [Abstract][Full Text] [Related]
17. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract][Full Text] [Related]
18. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
[TBL] [Abstract][Full Text] [Related]
19. Methylation in the p53 promoter in epithelial ovarian cancer.
Chmelarova M; Krepinska E; Spacek J; Laco J; Beranek M; Palicka V
Clin Transl Oncol; 2013 Feb; 15(2):160-3. PubMed ID: 22855178
[TBL] [Abstract][Full Text] [Related]
20. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
